Shoshana B Ginsburg1, Ahmad Algohary1, Shivani Pahwa2, Vikas Gulani2, Lee Ponsky3, Hannu J Aronen4, Peter J Boström5, Maret Böhm6, Anne-Maree Haynes6, Phillip Brenner7, Warick Delprado8, James Thompson6, Marley Pulbrock6, Pekka Taimen9, Robert Villani10, Phillip Stricker7, Ardeshir R Rastinehad11, Ivan Jambor4, Anant Madabhushi1. 1. Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, USA. 2. Department of Radiology, Case Western Reserve University, Cleveland, Ohio, USA. 3. Department of Urology, Case Western Reserve University, Cleveland, Ohio, USA. 4. Department of Diagnostic Radiology, University of Turku, Turku, Finland. 5. Department of Urology, Turku University Hospital, Turku, Finland. 6. Garvan Institute of Medical Research, Sydney, Australia. 7. Department of Urology, St. Vincent's Hospital, Sydney, Australia. 8. Douglass Hanly Moir Pathology, Sydney, Australia. 9. Department of Pathology, University of Turku and Turku University Hospital, Turku, Finland. 10. Department of Radiology, Hofstra North Shore-LIJ, New Hyde Park, New York, USA. 11. Department of Radiology, Icahn School of Medicine at Mount Sinai, Manhattan, New York, USA.
Abstract
PURPOSE: To evaluate in a multi-institutional study whether radiomic features useful for prostate cancer (PCa) detection from 3 Tesla (T) multi-parametric MRI (mpMRI) in the transition zone (TZ) differ from those in the peripheral zone (PZ). MATERIALS AND METHODS: 3T mpMRI, including T2-weighted (T2w), apparent diffusion coefficient (ADC) maps, and dynamic contrast-enhanced MRI (DCE-MRI), were retrospectively obtained from 80 patients at three institutions. This study was approved by the institutional review board of each participating institution. First-order statistical, co-occurrence, and wavelet features were extracted from T2w MRI and ADC maps, and contrast kinetic features were extracted from DCE-MRI. Feature selection was performed to identify 10 features for PCa detection in the TZ and PZ, respectively. Two logistic regression classifiers used these features to detect PCa and were evaluated by area under the receiver-operating characteristic curve (AUC). Classifier performance was compared with a zone-ignorant classifier. RESULTS: Radiomic features that were identified as useful for PCa detection differed between TZ and PZ. When classification was performed on a per-voxel basis, a PZ-specific classifier detected PZ tumors on an independent test set with significantly higher accuracy (AUC = 0.61-0.71) than a zone-ignorant classifier trained to detect cancer throughout the entire prostate (P < 0.05). When classifiers were evaluated on MRI data from multiple institutions, statistically similar AUC values (P > 0.14) were obtained for all institutions. CONCLUSION: A zone-aware classifier significantly improves the accuracy of cancer detection in the PZ. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:184-193.
PURPOSE: To evaluate in a multi-institutional study whether radiomic features useful for prostate cancer (PCa) detection from 3 Tesla (T) multi-parametric MRI (mpMRI) in the transition zone (TZ) differ from those in the peripheral zone (PZ). MATERIALS AND METHODS: 3T mpMRI, including T2-weighted (T2w), apparent diffusion coefficient (ADC) maps, and dynamic contrast-enhanced MRI (DCE-MRI), were retrospectively obtained from 80 patients at three institutions. This study was approved by the institutional review board of each participating institution. First-order statistical, co-occurrence, and wavelet features were extracted from T2w MRI and ADC maps, and contrast kinetic features were extracted from DCE-MRI. Feature selection was performed to identify 10 features for PCa detection in the TZ and PZ, respectively. Two logistic regression classifiers used these features to detect PCa and were evaluated by area under the receiver-operating characteristic curve (AUC). Classifier performance was compared with a zone-ignorant classifier. RESULTS: Radiomic features that were identified as useful for PCa detection differed between TZ and PZ. When classification was performed on a per-voxel basis, a PZ-specific classifier detected PZ tumors on an independent test set with significantly higher accuracy (AUC = 0.61-0.71) than a zone-ignorant classifier trained to detect cancer throughout the entire prostate (P < 0.05). When classifiers were evaluated on MRI data from multiple institutions, statistically similar AUC values (P > 0.14) were obtained for all institutions. CONCLUSION: A zone-aware classifier significantly improves the accuracy of cancer detection in the PZ. LEVEL OF EVIDENCE: 3 Technical Efficacy: Stage 2 J. MAGN. RESON. IMAGING 2017;46:184-193.
Authors: Jonathan Chappelow; B Nicolas Bloch; Neil Rofsky; Elizabeth Genega; Robert Lenkinski; William DeWolf; Anant Madabhushi Journal: Med Phys Date: 2011-04 Impact factor: 4.071
Authors: Ivan Jambor; Marko Pesola; Pekka Taimen; Harri Merisaari; Peter J Boström; Heikki Minn; Timo Liimatainen; Hannu J Aronen Journal: Magn Reson Med Date: 2015-03-02 Impact factor: 4.668
Authors: Barış Türkbey; Marcelino Bernardo; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke Journal: Diagn Interv Radiol Date: 2011-09-16 Impact factor: 2.630
Authors: Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi Journal: J Magn Reson Imaging Date: 2012-02-15 Impact factor: 4.813
Authors: Thomas Hambrock; Pieter C Vos; Christina A Hulsbergen-van de Kaa; Jelle O Barentsz; Henkjan J Huisman Journal: Radiology Date: 2012-11-30 Impact factor: 11.105
Authors: José Fernando García Molina; Lei Zheng; Metin Sertdemir; Dietmar J Dinter; Stefan Schönberg; Matthias Rädle Journal: PLoS One Date: 2014-04-03 Impact factor: 3.240
Authors: Prathyush Chirra; Patrick Leo; Michael Yim; B Nicolas Bloch; Ardeshir R Rastinehad; Andrei Purysko; Mark Rosen; Anant Madabhushi; Satish E Viswanath Journal: J Med Imaging (Bellingham) Date: 2019-06-14
Authors: B M Zeeshan Hameed; Aiswarya V L S Dhavileswarapu; Syed Zahid Raza; Hadis Karimi; Harneet Singh Khanuja; Dasharathraj K Shetty; Sufyan Ibrahim; Milap J Shah; Nithesh Naik; Rahul Paul; Bhavan Prasad Rai; Bhaskar K Somani Journal: J Clin Med Date: 2021-04-26 Impact factor: 4.241